DARWIN MOLECULAR CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

  • No Technology to Display

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

  • No Recent Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8236541 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activitiesExpiredDec 29, 10Aug 07, 12[C07H, C12N]
2012/0149,890 Polynucleotides Encoding Thymidine Kinase MutantsAbandonedNov 30, 11Jun 14, 12[C07H]
2012/0142,071 Thymidine Kinase MutantsAbandonedNov 30, 11Jun 07, 12[C12N]
8163528 Nucleic acid molecules encoding thymidine kinase fusion proteinsExpiredDec 29, 10Apr 24, 12[C07H, C12N]
7888091 Fusion proteins having thymidine kinase and guanylate kinase activitiesExpiredMay 08, 09Feb 15, 11[C07H, C12N]
7888114 Nucleic acids encoding fusion proteins having thymidine kinase and guanylate kinase activitiesExpiredMay 08, 09Feb 15, 11[C07H, C12N]
2009/0169,543 Method for regulating immune function in primates using the Foxp3 proteinAbandonedNov 06, 08Jul 02, 09[A61K, C12Q, A61P, C07K]
7507542 Method for regulating immune function using the FOXP3 proteinExpiredMay 08, 02Mar 24, 09[G01N]
6777432 Pharmaceutical uses and synthesis of nicotinamidesExpiredSep 04, 02Aug 17, 04[A61K, C07D]
2002/0037,827 Novel matrix metalloproteinase (MMP-25) expressed in skin cellsAbandonedMar 06, 01Mar 28, 02[A61K, C07H, C12P, C12N, A01K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.